1. Home
  2. GFAI vs BLRX Comparison

GFAI vs BLRX Comparison

Compare GFAI & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.61

Market Cap

13.1M

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$2.65

Market Cap

12.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFAI
BLRX
Founded
2018
2003
Country
Singapore
Israel
Employees
1698
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
12.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
GFAI
BLRX
Price
$0.61
$2.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.50
$19.00
AVG Volume (30 Days)
2.8M
10.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.66
N/A
Revenue Next Year
$4.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$2.30
52 Week High
$1.50
$7.77

Technical Indicators

Market Signals
Indicator
GFAI
BLRX
Relative Strength Index (RSI) 56.29 40.92
Support Level $0.55 $2.66
Resistance Level $0.70 $3.93
Average True Range (ATR) 0.09 0.18
MACD 0.02 -0.01
Stochastic Oscillator 49.19 25.18

Price Performance

Historical Comparison
GFAI
BLRX

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: